Combination products with tyrosine kinase inhibitors and their use

Combination products with tyrosine kinase inhibitors and their use

  • CN 104,245,701 A
  • Filed: 04/03/2013
  • Published: 12/24/2014
  • Est. Priority Date: 04/03/2012
  • Status: Active Application
First Claim
Patent Images

1. a drug regimen, described combination comprises (i) MET tyrosine kinase inhibitor and (ii) EGFR tyrosine kinase inhibitor, or its pharmaceutically-acceptable salts or its prodrug separately separately, and at least one pharmaceutically acceptable carrier.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×